EUVIMEDEUVIMED entdecken
Crossref

Amplification-Free Nucleic Acid Testing with a Fluorescence One-Step-Branched DNA-Based Lateral Flow Assay (FOB-LFA)

Kai Sun, Xueqi Wang, Yuxin Qu, Han Wang iD, Jing Cheng

Analytical Chemistry · 2023

DOI: 10.1021/acs.analchem.3c02299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2023. Verfasst von Kai Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Tsinghua University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of the global pandemic and the discovery of nucleic acid biomarkers in cancer diagnosis have fostered the development of more accurate and adaptive molecular diagnosis technologies. Current nucleic acid testing (NAT) methods either lack sensitivity or require tedious amplification operations, which could not meet the need for point-of-care (POC) NAT for on-site and community-based diagnosis. Here, we present a fluorescence one-step-bDNA-based lateral flow assay (FOB-LFA) method for amplification-free NAT to realize point-of-care pathogen detection and disease diagnosis. Take COVID-19 as an example, the developed FOB-LFA demonstrated a high sensitivity of 300 copies/mL for the RNA of the SARS-CoV-2 pseudovirus and exhibited high specificity among various homologous pseudoviruses. Further, the result of oropharyngeal swab sample detection suggested the great potential of FOB-LFA in clinical examination. The outstanding performance of FOB-LFA, including high sensitivity, high specificity, low cost, excellent portability, and minimized risk of nucleic acid leakage and contamination, can meet the POC testing demand for the diagnosis of various infectious and genetic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Branched DNA Signal Amplification AssayRNADNA

Substanzen

RNADNA

Autor:innen und Institutionen

  • Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing 100084, China.
  • National Engineering Research Center for Beijing Biochip Technology, Beijing 102200, China.

ORCID-Profile: Han Wang

Förderung

  • National Key Research and Development Program of China
  • Tsinghua University
  • National Natural Science Foundation of China

Zitieren

APA

Sun, K., Wang, X., Qu, Y., Wang, H., & Cheng, J. (2023). Amplification-Free Nucleic Acid Testing with a Fluorescence One-Step-Branched DNA-Based Lateral Flow Assay (FOB-LFA). Analytical Chemistry. https://doi.org/10.1021/acs.analchem.3c02299

Vancouver

Sun K, Wang X, Qu Y, Wang H, Cheng J. Amplification-Free Nucleic Acid Testing with a Fluorescence One-Step-Branched DNA-Based Lateral Flow Assay (FOB-LFA). Analytical Chemistry. 2023. doi:10.1021/acs.analchem.3c02299

BibTeX
@article{Sun2023,
  author = {Sun, Kai and Wang, Xueqi and Qu, Yuxin and Wang, Han and Cheng, Jing},
  title = {Amplification-Free Nucleic Acid Testing with a Fluorescence One-Step-Branched DNA-Based Lateral Flow Assay (FOB-LFA)},
  journal = {Analytical Chemistry},
  year = {2023},
  doi = {10.1021/acs.analchem.3c02299}
}
Kostenlos starten →